I make a donation

AFLOAT

Efficiency of flecainide to prevent AF occurence after PFO closure

En cours

Bourses ACTION & PHRA 2022

Colloquium "La cardiologie préventive : nouveautés" (mardi 1er avril 2025)
Réservez vos places !

La Fondation de l'AP-HP attribue le Grand Prix Scientifique 2024 au Pr Gilles Montalescot

La Grande Journée du Coeur (jeudi 26 juin 2025)
Réservez votre après-midi !

P&R Agenda
Au programme prochainement...

objectif

To assess if flecainide is more efficient than standard of care (control group) to prevent AF occurrence during the 3 months after PFO closure.

date de réalisation

2021

nombre de patients

186

nombre de centres participants

16 french sites

type de financement

Fonds de Dotation Action & Abbott

Référence

NCT05213104

A study conducted by Fonds de Dotation ACTION.
Find out details and results on the dedicated page

AFLOAT conducted by Fonds de Dotation ACTION

Autres études

ADEN

En cours

Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications i...

ANCHOR

En cours

Demonstrate the superiority of an association of VA-ECMO and IABP with an optimal medical treatment compared with an optimal medical treatment only in cardiogenic shock AMI patients

BIO-TAVI

En cours

Correlation between the platelet reactivity, the von Willebrand factor and bleeding and thrombotic events occuring during the year following TAVI